Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Abstract Emphasizing the significance of cancer-associated fibroblasts (CAFs), non-malignant yet pivotal players within the tumor microenvironment (TME), this review illuminates the role of inflammatory subtype (iCAF) as catalysts in cancer proliferation, metastasis, and therapeutic resistance. Give...
Saved in:
Main Authors: | Zhongsong Zhang, Long Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Cancer Nanotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12645-024-00302-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
by: Zhang Z, et al.
Published: (2025-01-01) -
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
by: Zhipeng Cao, et al.
Published: (2025-01-01) -
Cancer-associated fibroblasts in carcinogenesis
by: Shufen Zhou, et al.
Published: (2025-01-01) -
Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer
by: Yuwei Yao, et al.
Published: (2025-02-01) -
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)